Nick Coleman

Nick Coleman is a Principal at Excellere Partners, a Denver-based private equity firm founded in 2006 that partners with entrepreneurs and management teams through growth recapitalizations and management buyouts. He joined the firm in 2013 and has risen through its investment ranks, being promoted to Vice President in February 2019 and to Principal on March 2, 2023. In announcing the latter promotion, Managing Partner Brad Cornell said, "Nick exemplifies the next generation of leaders we are building at Excellere."

Before Excellere, Coleman worked as an Analyst at Northwestern Mutual Capital, LLC, the private investment arm of Northwestern Mutual Life Insurance Company, where he provided mezzanine debt and equity co-investments for private equity sponsor-backed portfolio companies. His work there centered on structuring, underwriting, and monitoring investments across a range of industries and asset classes — experience that maps directly to his current responsibilities arranging debt financing and executing deals.

At Excellere, Coleman evaluates and executes new investment opportunities, arranges debt financing, and supports value-creation initiatives, portfolio-company management, and liquidity planning. He has been a key deal-team member on Excellere portfolio companies including LucidHealth, Medlogix, and Biocare Medical — all concentrated in the firm's healthcare franchise. He earned his Bachelor of Business Administration from the University of Wisconsin.

• Invests as a control/growth private equity investor, not an angel or seed backer — Excellere targets lower-middle-market platforms (revenues ~$25M–$150M) and executes management buyouts and growth recapitalizations, then builds them via add-on acquisitions.
• Concentrates on three sectors: Healthcare, Industrial Growth, and Business Services, with Coleman's own track record squarely in healthcare (radiology services, medical claims management, pathology/medical products).
• Uses a research-driven, top-down strategy: the firm identifies attractive sub-sectors, then seeks companies with proven revenue growth, stable margins, defensible niches, intellectual property, strong brand identity, and management teams it can partner with.
• Says yes to companies with a clear value proposition and platform potential — Excellere aims for ~10–12 platform investments per fund and drives value through operational initiatives and buy-and-build M&A.
• Coleman's personal remit — arranging debt financing and portfolio liquidity planning — signals a focus on capital structure and exit outcomes alongside sourcing.